Skip to main content
. 2015 Oct 14;10(10):e0140112. doi: 10.1371/journal.pone.0140112

Table 2. Clinical and microbiological factors and their association with nasopharyngeal pneumococcal density.

Univariate analysis on 57 patients if not otherwise stated.

Factor log10 DNA copies/mL
No. with factor/No. without factor With factor, median pneumococcal density (interquartile range) Without factor, median pneumococcal density (interquartile range) P- value
Female gender 27/30 7.05 (6.22–7.95) 6.72 (5.59–7.66) 0.35
Age ≥65 years 34/23 6.77 (5.78–7.66) 6.86 (6.29–7.74) 0.49
Co-morbidity a 33/24 6.71 (6.09–7.66) 6.84 (6.14–7.86) 0.72
Smoking, current or previous 35/22 6.83 (6.22–7.67) 6.79 (5.95–7.76) 0.83
Viral co-infection 14/43 7.35 (6.62–7.76) 6.71 (5.59–7.67) 0.31
Pneumonia severity index risk class IV-V 23/34 7.47 (6.24–7.97) 6.58 (5.95–7.56) 0.04
Symptoms ≥2 days prior to admission 37/20 7.05 (6.29–7.71) 6.26 (5.46–7.70) 0.10
Respiratory rate ≥ 30 20/37 7.22 (6.28–8.10) 6.66 (5.95–7.65) 0.12
Positive blood culture 12/45 6.94 (6.02–8.10) 6.73 (6.22–7.66) 0.61
Positive urine antigen test 33/24 6.71 (5.78–7.67) 6.99 (6.30–7.73) 0.56
Bilateral chest X-ray infiltrates 16/41 7.36 (6.70–8.00) 6.62 (6.07–7.66) 0.10
Admission to intensive care unit 3/54 8.06 (7.67–9.50) 6.72 (6.07–7.66) 0.03
Serotype with high degree of encapsulation b 26/23 7.47 (6.42–7.79) 6.66 (6.22–7.97) 0.31
Medium/high S-Ig titer to the patient´s own serotype 30/17 7.61 (6.39–8.06) 6.66 (5.71–7.20) 0.008

a Solid tumor, blood malignancy, liver disease, renal disease, chronic obstructive pulmonary disease, heart disease, stroke, diabetes.

b Serotypes 3, 6B, 11A, 12F, 19A, 19F, 23F, and 35B.